1126425-15-7

Basic information

• Product Name: 6-Fluoro-1H-indazole-5-carbaldehyde
• Synonyms: 1H-Indazole-5-carboxaldehyde, 6-fluoro-
• CAS NO: 1126425-15-7
• Molecular Formula: C₈H₅FN₂O
• Molecular Weight: 164.137
• Mol File: 1126425-15-7.mol
• Article Data: 10

Chemical Properties

• CAS DataBase Reference: 6-Fluoro-1H-indazole-5-carbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Fluoro-1H-indazole-5-carbaldehyde(1126425-15-7)
• EPA Substance Registry System: 6-Fluoro-1H-indazole-5-carbaldehyde(1126425-15-7)

Safety Data

• Hazardous Substances Data: 1126425-15-7(Hazardous Substances Data)

Usage

General Description

6-Fluoro-1H-indazole-5-carbaldehyde is a chemical compound with the molecular formula C9H6FN2O. It is a heterocyclic compound containing both nitrogen and fluorine atoms. This chemical is commonly used in organic synthesis and pharmaceutical research as a building block for the construction of various indazole derivatives, which have potential applications in the development of new drugs and agrochemicals. It is known for its valuable properties in medicinal chemistry, including anti-inflammatory, antibacterial, and anticancer activities. The compound is also used in the synthesis of fluorescent materials and dyes. Overall, 6-Fluoro-1H-indazole-5-carbaldehyde plays a significant role in the development of diverse compounds with important industrial and medicinal applications.

Upstream product

• 633335-81-6 1-(5-bromo-6-fluoro-1H-indazol-1-yl)ethan-1-one 
• 633335-80-5 N-(4-bromo-5-fluoro-2-methylphenyl)acetamide 
• 367-29-3 3-fluoro-6-methylaniline 
• 366-49-4 5’-fluoro-2’-methylacetanilide 
• 105391-70-6 5-bromo-6-fluoro-1H-indazole 
• 68-12-2 N,N-dimethyl-formamide 
• 633327-11-4 6-fluoro-1H-indazole-5-carbonitrile 

Relevant articles and documents

Optimization of potency and pharmacokinetics of tricyclic indole derived inhibitors of HCV NS5B polymerase. Identification of ester prodrugs with improved oral pharmacokinetics

HCV infections are the leading causes for hepatocellular carcinoma and liver transplantation in the United States. Recent advances in drug discovery have identified direct acting antivirals which have significantly improved cure rates in patients. Current

FLUORO-SUBSTITUTED 3,5-DICYANO-4-(1H-INDAZOL-5-YL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE DERIVATIVES AND METHODS OF USE THEREOF

The present invention relates to novel fluoro-substituted 3,5-dicyano-4-(1H-indazol-5-yl)-2,6-dimethyl-1,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for

ANNELLATED 4- (INDAZOLYL) -1,4-DIHYDROPYRIDINE DERIVATIVES AND METHODS OF USE THEREOF

This invention relates to novel annellated 4-(indazolyl)-l,4-dihydropyridine derivatives having protein tyrosine kinase inhibitory activity, to a process for the manufacture thereof and to the use thereof for the treatment of c-Met-mediated diseases or c-